News

August 18, 2015

Exploring Statins to Decrease HIV-Related Heart Disease Risk

Antiretroviral therapy (ART) has been a lifeline for untold numbers of patients with HIV. But as mounting evidence shows the infection may increase their risk of […]
July 30, 2015

REPRIEVE featured in JAMA

JAMA article highlights REPRIEVE trial for studying ways to prevent HIV-Related Heart Disease! Individuals living with HIV are at increased risk of heart disease.
July 27, 2015

REPRIEVE for Heart Disease in HIV

REPRIEVE was recently featured online in POZ. Click here to read more!
May 27, 2015

REPRIEVE and Washington University Featured in the St. Louis Post-Dispatch

Washington University's participation in the REPRIEVE trial is featured in the St. Louis Post-Dispatch!
May 1, 2015

Novel mechanisms and potential treatment strategies for CVD in HIV patients

Epidemiological studies suggest cardiovascular disease, including myocardial infarction and stroke, are increased 50% to 100% among HIV patients compared with non-HIV patients. Moreover, data suggest cardiovascular […]
April 24, 2015

Exciting News from MGH About the REPRIEVE Trial

Exciting news from Massachusetts General Hospital about the REPRIEVE trial!
April 15, 2015

NIH Announces REPRIEVE Trial Launch

NHLBI and NIAID announce launch of the REPRIEVE Trial:
March 13, 2015

Dr. Monica Shah Publishes on High Priority Research Including REPRIEVE Trial

Please see attached link to article “Stimulating High Impact HIV-Related Cardiovascular Research: Recommendations From a Multidisciplinary NHLBI Working Group on HIV-Related Heart, Lung, and Blood Disease” by Dr. Monica Shah published in the February 24, 2015 issue of the Journal of the American College of Cardiology.
March 11, 2015

Importance of REPRIEVE Trial Highlighted at CROI 2015

REPRIEVE Trial highlighted by Dr. Steven Grinspoon, Co-PI of the REPRIEVE Trial at HIV Conference/CROI 2015, in Seattle, WA.